Last reviewed · How we verify

NCT03525249: FISMEH

Clinical Trial on the Articular Pain of Diagnosed Patients of Arthrosis

Completed NA Last updated 18 October 2019
What this trial tests

NA trial testing nutraceutical in Osteoarthritis in 87 participants. Completed in 30 September 2018.

Timeline
20 March 2018
Primary endpoint
30 September 2018
30 September 2018

Quick facts

Lead sponsorUniversidad Católica San Antonio de Murcia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment87
Start date20 March 2018
Primary completion30 September 2018
Estimated completion30 September 2018
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Católica San Antonio de Murcia

Who can join

Adults 18 to 75, any sex, with Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized, controlled, double-blind clinical trial of three parallel branches to analyze the efficacy of a supplement extracted from the internal membrane of the egg shell on the joint pain of patients diagnosed with osteoarthritis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of nutraceutical

Trials testing the same drug.

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

Other Universidad Católica San Antonio de Murcia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing